July 02, 2026

Transdermal NSAID Matches Oral Celecoxib After Knee Replacement

Randomized trial finds a topical anti-inflammatory patch provided similar pain relief, function, and safety as oral therapy during the first 6 weeks after surgery.

Conexiant

July 01, 2026

Medical Oddities: Do Jellyfish Hold a Healing Secret?

Jellyfish, pets, watermelon, brain implants, and fennel fuel this week's surprises.

Conexiant

June 24, 2026

Do Revisions in Rotator Cuff Repair Decline With GLP-1 Use?

Preoperative use was associated with fewer revisions and no increase in short-term complications among patients with obesity, although benefits appeared concentrated in select subgroups.

Conexiant

June 22, 2026

PRP Linked to Better Outcomes in Advanced Knee OA

In a small open-label randomized trial, 2 platelet-rich plasma injections were associated with greater 6-month improvements in pain and function than corticosteroid injection or oral aceclofenac among patients awaiting knee arthroplasty.

Conexiant

June 19, 2026

Pain Linked to Arthroplasty Satisfaction

A Geneva registry study points surgeons toward residual pain over functional limitation as the outcome that tracks patient satisfaction one year after hip or knee replacement.

Conexiant

June 11, 2026

When Bad Data Enters the Drug Pipeline

Federal prosecutors allege that a Florida physician and research staff fabricated clinical trial records that were submitted into database systems used to evaluate investigational drugs.

Conexiant

June 03, 2026

Medical Oddities: Prayer for Pain?

This week’s research collection showed that biology, behavior, and environment often intersect in unexpected ways.

Conexiant

June 01, 2026

CAA Use Tied to Higher Arthroplasty Risk

In a UK cohort, patients with osteoarthritis who initiated centrally acting analgesics had a higher hazard of knee or hip replacement than those who initiated SSRIs, though residual confounding by pain severity remains a key limitation.

Conexiant

May 29, 2026

FDA Expands Guselkumab Label in PsA

Phase 3b APEX findings support the addition of structural joint damage inhibition data to the prescribing information.

Conexiant

May 29, 2026

RA Prescribing Patterns Shift Over 15 Years

An aging Japanese cohort with rheumatoid arthritis saw increasing use of targeted synthetic therapies as glucocorticoid use declined.

Conexiant